About this trial

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged between 6 to 18 years old;

Children in accordance with the guidelines for the Diagnosis and Treatment of 12 Diseases related to hematologic diseases and malignant tumors (2021 version) issued by the General Office of the National Health Commission;

At least experience one full cycle of chemotherapy;

Children with moderate or higher symptoms of decreased appetite were screened for a list of treatment-related symptoms.

Disqualifiers

Children with serious cardiopulmonary disease, infection, organ damage, or genetic metabolic disease, immune deficiency disease, mental illness;

Children with eye or ear dysfunction that prevents them from watching and listening to videos.

Trial design

Design model

Parallel

Treatments tested in this trial

Active Ingredient Mukbang
Behavioral
Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.
General short videos
Behavioral
Short videos that don't contain any food cues.

Treatment groups

124 Participants

are divided into 2 treatment groups

Group A: Active Ingredient MukbangExperimental treatment 1 intervention

Group B: General short videosPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Self-reported appetite during the intervention

A subjective sensation that stimulates the intake of food to provide the energy necessary for the most basic activities of life, which can be measured by the Cancer Appetite and Symptom Questionnaire (CASQ).

Time frame

Change from baseline appetite during 7 days intervention

2

Self-reported appetite during the intervention

A subjective sensation that stimulates the intake of food to provide the energy necessary for the most basic activities of life, which can be measured by the Cancer Appetite and Symptom Questionnaire (CASQ).

Time frame

Change from baseline appetite at 4 weeks follow-up

Secondary outcomes

1

The level of nutritional status

Insufficient or excessive nutrient intake, imbalance of essential nutrients or impaired nutrient utilization, mainly manifested by wasting, stunting, underweight and micronutrient deficiency. Malnutrition is measured by the Subjective Global Nutritional Risk Assessment (SGNA).

Time frame

Change from baseline nutritional status at 7 days

2

The level of nutritional status

Insufficient or excessive nutrient intake, imbalance of essential nutrients or impaired nutrient utilization, mainly manifested by wasting, stunting, underweight and micronutrient deficiency. Malnutrition is measured by the Subjective Global Nutritional Risk Assessment (SGNA).

Time frame

Change from baseline nutritional status at 4-weeks follow-up

3

The level of the body mass index of the children with cancer

Body mass index (BMI), a simple method to evaluate the nutritional status and changes of children with cancer, which will be calculated as weight/height\^2. Weight and height will be combined to report BMI in kg/m\^2.

Time frame

Change from baseline BMI at 7 days

4

The level of the body mass index of the children with cancer

Body mass index (BMI), a simple method to evaluate the nutritional status and changes of children with cancer, which will be calculated as weight/height\^2. Weight and height will be combined to report BMI in kg/m\^2.

Time frame

Change from baseline BMI at 4-weeks follow-up

Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

About this trial

Eligibility criteria

Qualifiers

Disqualifiers

Trial design

Treatments tested in this trial

Treatment groups

Trial outcomes

Primary outcomes

Secondary outcomes

Other outcomes

Sponsors and contacts